The decline of HBV RNA associated with HBeAg seroconversion and double-negative HBV DNA and RNA in chronic hepatitis B patients who received entecavir therapy: a 10-year retrospective cohort study

BACKGROUND: Whether the decline of hepatitis B virus (HBV) RNA was associated with antiviral efficacy in chronic hepatitis B (CHB) patients receiving long-term nucleos(t)ide analogues (NAs) therapy remains unclear. We observed the levels of serum HBV RNA in CHB patients treated with entecavir (ETV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Feng, Zhao, Wenjuan, Yang, Xueliang, Zhang, Xi, An, Xiaocui, Zhu, Ruixue, Chen, Yunru, Liu, Xiaojing, Li, Jianzhou, Li, Kang, Zheng, Jie, Lin, Shumei, Shi, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469125/
https://www.ncbi.nlm.nih.gov/pubmed/36110993
http://dx.doi.org/10.21037/atm-22-3265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469125/
https://www.ncbi.nlm.nih.gov/pubmed/36110993
http://dx.doi.org/10.21037/atm-22-3265

Ejemplares similares